#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 51

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hormone-refractory prostate cancer+1

Recruiting

Registered drugNo placebo

A study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Systemic scleroderma+4

Recruiting

InvestigationalNo placebo

A long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Kyv-101

Contact Research Centre

Peripheral arterial occlusive disease+5

Recruiting

Registered drug

A study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Clopidogrel

Contact Research Centre

Chronic kidney disease

Recruiting

Registered drug

Study of the effect of empagliflozin on protein levels in the urine for patients with type 2 diabetes and kidney disease.

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Empagliflozin

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

Registered drugNo placebo

Study of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Herpes zoster

Recruiting

Registered drugNo placebo

Evaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster

Registered drugNo placebo

Denmark

Participants:65+ years · Healthy volunteers
Substances:Recombinant Varicella Zoster Virus Glycoprotein E

Contact Research Centre

Monogenic diabetes

Recruiting

Registered drugNo placebo

Increasing the dose of glimepiride for patients with HNF1A-MODY or HNF4A-MODY diabetes

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Glimepiride

Contact Research Centre

Chronic kidney disease+1

Recruiting

Registered drugNo placebo

Effect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Levothyroxine

Contact Research Centre

Hepato-lenticular degeneration

Recruiting

Registered drug

A study comparing different zinc doses for the treatment of Wilson disease in healthy participants.

Registered drug

Denmark

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Copper (64Cu) Chloride

Contact Research Centre

Pyelonephritis

Recruiting

Registered drugNo placebo

Comparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ceftriaxone

Contact Research Centre

Cardiac function disturbance postoperative+1

Recruiting

Registered drug

A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:R2R01

Contact Research Centre

Systemic scleroderma+5

Recruiting

InvestigationalNo placebo

Using 68Ga-FAPI-46 imaging to detect fibrosis in patients with inflammatory diseases such as Crohn's disease, ulcerative colitis, systemic sclerosis, and lung fibrosis.

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.